Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Wednesday that its board of directors has approved a dividend for the fourth quarter of 2023.
The dividend of USD1.13 per share on outstanding common stock is payable to shareholders of record at 15 November 2023 on 8 December 2023.
Abbott announces quarterly common dividend
West Pharmaceutical Services announces Q2 dividend
Perrigo increases quarterly dividend
AbbVie announces quarterly cash dividend
hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026
OptiBiotix expands into Indian market with Amazon launch
Poxel to receive royalties and sales-based payment from Sumitomo Pharma
ReciBioPharm secures grant to expand RNA manufacturing in LMICs
CVS Health to pays common stock quarterly dividend of USD0.665 per share
TC BioPharm receives shareholders' approval for 25% stock dividend
USANA Health Sciences acquires controlling stake in Hiya Health for USD205m
Valneva and Serum Institute of India partner to expand chikungunya vaccine access in Asia
Lilly and EVA Pharma granted regulatory approval for locally manufactured insulin in Egypt
Abbott announces dividend increase and 53 years of growth
SK bioscience begins clinical trials for mRNA Japanese encephalitis vaccine